The FDA’s removal of hormone therapy warnings after 23 years validates what many women suspected.
“Was I misled?”
That’s the question I hear most from my patients lately—asked with anger, exhaustion, and the quiet devastation of women who wonder if they lost years of their lives to menopause symptoms they were told were untreatable.
The answer came earlier this month when the U.S. Food and Drug Administration announced it would remove “black box” warnings from hormone therapy products after 23 years. For many women, the reversal is an admission that arrives decades too late.
What Happened in 2002
In July 2002, preliminary data from the Women’s Health Initiative (WHI) were published in JAMA, showing that combined hormone therapy (estrogen and progestin) increased the risk of breast cancer, stroke, and pulmonary embolism. Major media outlets interpreted early signals from the study as definitive danger, and the announcement led to an instant and dramatic decline in the use of hormone therapy.
Women who had been sleeping well for the first time in years suddenly poured their medications into the trash. Pharmacies fielded calls from panicked patients demanding immediate discontinuation. Primary care doctors, most of whom had never been trained deeply in menopause management, told their patients to “stop now and ask questions later.”
Women did stop, and many suffered in silence for the next 20 years.
The FDA’s Historic Reversal
On Nov. 10, the FDA announced that it is initiating the removal of broad “black box” warnings referencing risks of cardiovascular disease, breast cancer, and probable dementia from hormone replacement therapy products for menopause.
When FDA Commissioner Dr. Marty Makary spoke publicly about the shift, he didn’t mince words. He said the media had frightened women away from a potentially life-changing therapy, and he noted the difference between estrogen-only therapy and synthetic combination regimens. He acknowledged, openly, that the “fear machine” had begun long before the scientific data had been fully understood.
He also said something that struck many women deeply: “After 23 years of dogma, the FDA is stopping the fear that has steered women away from this life-saving treatment.”
For many of my patients, that sentence felt like a validation they had waited half a lifetime to hear.
